Sinopharm Group Co (X2S1) Income Statement
Sinopharm Group Co Income Statement
Last quarter (Q2 2026), Sinopharm Group Co's total revenue was $279.68B, a decrease of 5.11% from the same quarter last year. In Q2, Sinopharm Group Co's net income was $3.37B. See Sinopharm Group Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 559.50B | $ 584.51B | $ 596.57B | $ 552.15B | $ 521.05B | |
| $ 40.09B | $ 44.26B | $ 48.51B | $ 47.43B | $ 44.05B | |
| $ 23.88B | $ 28.07B | $ 28.30B | $ 26.83B | $ 24.34B | |
| Depreciation and Amortization | $ 4.29B | $ 4.73B | $ 4.43B | $ 4.17B | $ 3.92B |
| $ 20.50B | $ 22.55B | $ 26.90B | $ 26.25B | $ 24.68B | |
| $ 16.21B | $ 16.19B | $ 20.21B | $ 20.60B | $ 19.71B | |
| $ -1.82B | $ -2.19B | $ -697.06M | $ -2.04B | $ -2.71B | |
| $ 14.40B | $ 14.00B | $ 19.51B | $ 18.56B | $ 17.00B | |
| $ 6.96B | $ 7.05B | $ 9.05B | $ 8.53B | $ 7.76B | |
| Per Share Metrics | |||||
| Basic EPS | $ 11.10 | $ 11.30 | $ 14.50 | $ 13.65 | $ 12.45 |
| Diluted EPS | $ 11.10 | $ 11.30 | $ 14.50 | $ 13.65 | $ 12.45 |
| Weighted Average Shares Outstanding | 624.11M | 624.11M | 624.13M | 624.13M | 622.23M |
| Weighted Average Shares Outstanding (Diluted) | 624.11M | 624.11M | 624.13M | 624.13M | 622.23M |
Currency in CNY